Submitted by Anonymous (not verified) on 9 October 2024 - 15:18
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 6, Status: Authorised